Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Multi-responsive tetrahedral DNA frameworks for <i>in situ</i> methyltransferase imaging to distinguish living chemoresistant tumor cells.

Chemical science·2026
Same author

Ordered DNA Cube-Braced Hierarchical Ladder Track-Confined Efficient Circular DNA Walker for Rapid and Ultrasensitive Electrochemical Detection of UDG Activity.

Analytical chemistry·2026
Same author

A Synergistic DNA Walker-Track System with Tailored Spatial Compatibility for Rapid and Ultrasensitive Electrochemical Detection of MUC1.

Analytical chemistry·2026
Same author

Sequence-Resolved Imaging of mRNA G-Quadruplexes for Profiling the Translational Suppression in Oncogene Expression.

Analytical chemistry·2026
Same author

Conductive Dual Dynamic Cross-Linked H<sup>+</sup>-Responsive Hydrogel for Electrochemical Sensitive Monitoring of Carbonic Anhydrase Activity.

Analytical chemistry·2026
Same author

Progression of non-radiographic to radiographic axial spondyloarthritis: a risk model based on a chinese cohort study.

BMC rheumatology·2026

Related Experiment Video

Updated: May 5, 2026

Author Spotlight: Advancements in DNA Nanosensors &#8211; Addressing Sensitivity and Selectivity Challenges in Molecular Detection
07:16

Author Spotlight: Advancements in DNA Nanosensors – Addressing Sensitivity and Selectivity Challenges in Molecular Detection

Published on: February 9, 2024

1.8K

Dichromatically Encoded DNA Nanodevice for High-Resolution Molecular Subtyping of Triple-Negative Breast Cancer.

Zhao-Peng Chen1, Lu-Xi Wang1, Xue-Mei Zhou1

  • 1MOE Key Laboratory of Luminescence Analysis and Molecular Sensing, College of Chemistry and Chemical Engineering, Southwest University, Chongqing 400715 P. R. China.

Analytical Chemistry
|May 4, 2026
PubMed
Summary

A novel DNA nanodevice, DRIVE, precisely subtypes triple-negative breast cancer (TNBC) by detecting key biomarkers. This advance enhances cancer diagnostics and personalized medicine through accurate molecular subtyping.

More Related Videos

Detection of a CDH1 Rare Transcript Variant in Fresh-frozen Gastric Cancer Tissues by Chip-based Digital PCR
09:16

Detection of a CDH1 Rare Transcript Variant in Fresh-frozen Gastric Cancer Tissues by Chip-based Digital PCR

Published on: February 5, 2018

5.6K
DNA-barcode-based Multiplex Immunofluorescence Imaging to Analyze FFPE Specimens from Genetically Reprogrammed Murine Melanoma
09:58

DNA-barcode-based Multiplex Immunofluorescence Imaging to Analyze FFPE Specimens from Genetically Reprogrammed Murine Melanoma

Published on: June 6, 2025

1.2K

Related Experiment Videos

Last Updated: May 5, 2026

Author Spotlight: Advancements in DNA Nanosensors &#8211; Addressing Sensitivity and Selectivity Challenges in Molecular Detection
07:16

Author Spotlight: Advancements in DNA Nanosensors – Addressing Sensitivity and Selectivity Challenges in Molecular Detection

Published on: February 9, 2024

1.8K
Detection of a CDH1 Rare Transcript Variant in Fresh-frozen Gastric Cancer Tissues by Chip-based Digital PCR
09:16

Detection of a CDH1 Rare Transcript Variant in Fresh-frozen Gastric Cancer Tissues by Chip-based Digital PCR

Published on: February 5, 2018

5.6K
DNA-barcode-based Multiplex Immunofluorescence Imaging to Analyze FFPE Specimens from Genetically Reprogrammed Murine Melanoma
09:58

DNA-barcode-based Multiplex Immunofluorescence Imaging to Analyze FFPE Specimens from Genetically Reprogrammed Murine Melanoma

Published on: June 6, 2025

1.2K

Area of Science:

  • Biotechnology
  • Molecular Diagnostics
  • Nanotechnology

Background:

  • Accurate cancer subtyping is crucial for personalized medicine.
  • Current diagnostic methods struggle with multiplexing complex biomarker signatures.
  • Triple-negative breast cancer (TNBC) requires precise subtyping for effective treatment.

Purpose of the Study:

  • To develop a high-resolution molecular subtyping method for TNBC.
  • To create a modular and dynamic DNA nanodevice for cancer diagnostics.
  • To enable multiplexed detection of cancer biomarkers using DNA nanotechnology.

Main Methods:

  • Development of a DNA nanodevice (DRIVE) with recognition and output modules.
  • Functionalization of a tetrahedral DNA scaffold with probes for APE1 activity and specific miRNAs.
  • Utilizing catalytic hairpin assembly (CHA) for signal amplification and dual-color output (FAM/Cy5).

Main Results:

  • DRIVE successfully detects apurinic/apyrimidinic endonuclease 1 (APE1) activity and specific microRNAs (miRNAs) like miRNA-21 and miRNA-210.
  • A significant amplification of signal was observed, with enhanced reaction kinetics compared to individual probes.
  • The dual-signal output enabled statistically significant differentiation of TNBC cells from other breast cancer subtypes.

Conclusions:

  • The DRIVE nanodevice provides precise molecular subtyping of TNBC.
  • This technology offers potential for accurate cancer diagnostics and personalized therapeutic strategies.
  • DRIVE's modularity and dynamic response advance the field of molecular diagnostics.